Peter Kissinger

This profile gathers the share dealings of Peter Kissinger across 2 companies, led by Inotiv, Inc. and Chembio Diagnostics, Inc. Between 28 February 2008 and 14 September 2018, the trades on record add up to 18 filings.

Both buying and selling appear: 2 purchases worth €21k, against 14 sales worth €13k. Netting one side against the other leaves €8,419 of net buying. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 option exercises. 2018 to date brings 1 purchase and no sales.

Most recently, on 18 September 2018, the filings show an open-market purchase worth €15k in Inotiv, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.